Trial intelligence / Profile preview

High versus low dose intravenous dexamethasone for immediate postoperative complications after mastectomy

2017-000227-27Phase 4Completed

Sponsor
Eske Kvanner Aasvang
Start
Jan 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone in breast cancer (2 arms), sponsored by Eske Kvanner Aasvang. Primary endpoint: Proportion of patients transferred to postanesthesia care unit post surgery. Started Jan 2017; status: completed.

02

Drugs

dexamethasone
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2017-000227-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000227-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call